Innovation1 Biotech Inc. (OTCPK: IVBT)
Health Care · Pharmaceuticals · US
$—
— today · — 1Y
Innovation1 Biotech Inc. (OTCPK: IVBT) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.49K and employs 1 people.
trading between 0.00 and 0.01.
Tweenvest scores Innovation1 Biotech Inc. across four factors: quality 7/100. Its strongest factor is quality.
IVBT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.49K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.30
- Dividend yield
- —
- Beta (5Y)
- 15.55
- 52-week high
- $0.01
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 22.47M
- Employees
- 1
- Next earnings
- —
About Innovation1 Biotech Inc.
Innovation1 Biotech Inc. functions as a drug discovery enterprise, primarily engaged in creating modified botanical Schedule 1 molecules for use within the United States. The firm's pipeline encompasses five entirely synthetic, proprietary prodrugs that are currently in preclinical development, each designed to tackle a unique set of medical conditions. Specifically, these include a psychedelic compound derived from mushrooms, aimed at treating post-traumatic stress disorder and depression; an innovative cannabinoid and tree bark-sourced psychedelic intended to combat addiction; and three additional cannabinoid prodrugs targeting refractory pediatric epilepsy, hypertrophic scarring, and inflammation of the eye. Established in 2014 and headquartered in New York, New York, the company was previously named Gridiron BioNutrients, Inc. before adopting its current moniker, Innovation1 Biotech Inc., in March 2022.
- ISIN
- US39809D2018
- Listed since
- Sep 22, 2017
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.06T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $650.67B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $377.72B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $365.10B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $300.07B | CHF127.18 | -0.90% |
| AstraZeneca PLCLSE: AZN | $257.89B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $210.23B | Dkr304.95 | -0.93% |
| Pfizer Inc.NYSE: PFE | $161.30B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.